Legislation introduced in the Senate on April 23 would give the US Food and Drug Administration (FDA) more resources to inspect domestic and foreign-made prescription drugs and devices.
Sen Chuck Grassley (R, Iowa) and Sen Ted Kennedy (D, Mass) introduced the Drug and Device Accountability Act of 2009 (S 882 [http://thomas.loc.gov]), which would expand the FDA's authority to inspect foreign manufacturers and importers, allow it to issue subpoenas, and give the agency the ability to detain a device or drug when its inspectors have reason to believe the product is adulterated or misbranded. The increased FDA workload would be funded by collecting inspection fees.
Mitka M. Enhancing FDA Inspections. JAMA. 2009;301(22):2318. doi:10.1001/jama.2009.782
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.